Skip to main content
. 2022 Jun 8;38(8):e1409–e1416. doi: 10.1097/PEC.0000000000002777

TABLE 1.

Adolescent and Young Adult Visit Characteristics Compared by Opioid Administration (ED-RX) and Prescribing (DC-RX) in EDs; NHAMCS 2014–2018

Unweighted No. Visits Weighted Visits, % (95% CI) Weighted Visits for
ED-RX, % (95% CI)*
P Weighted Visits for DC-RX, % (95% CI)* P
Total 12,693 12.2 (11.4–13.0) 12.3 (11.3–13.3) 11.5 (10.5–12.5)
Demographics
Age, mean (95% CI) 18.2 (SE = 0.08) 19.6 (19.3–19.9) <0.001 20.1 (19.9–20.4) <0.001
Sex 0.10 0.10
 Female 7430 58.6 (57.2–59.9) 11.8 (10.5–13.0) 11.0 (9.9–12.0)
 Male 5263 41.4 (40.1–42.8) 13.0 (11.7–14.3) 12.1 (10.7–13.6)
Race 0.08 0.02
 White 8794 70.7 (67.5–73.9) 12.8 (11.7–14.0) 12.2 (10.9–13.4)
 Other 3899 29.3 (26.1–32.5) 11.0 (9.3–12.7) 9.8 (8.3–11.3)
Ethnicity 0.09 0.02
 Hispanic or Latino 2356 17.4 (15.0–19.7) 10.6 (8.5–12.7) 9.4 (7.6–11.2)
 Not Hispanic or Latino 10,337 82.6 (80.3–85.0) 12.6 (11.6–13.7) 11.9 (10.8–13.0)
Primary payer 0.001 <0.001
 Blank/Unknown 1120 9.0 (6.8–11.3) 11.8 (8.0–15.6) 7.8 (5.7–9.9)
 Private insurance 4040 31.0 (29.2–32.9) 13.4 (11.7–15.1) 13.0 (11.1–14.9)
 Medicare/Medicaid/State-Based 5727 44.0 (41.4–46.6) 10.3 (9.0–11.6) 9.1 (8.0–10.1)
 Other 1806 15.9 (14.1–17.7) 15.9 (13.2–18.6) 17.2 (14.9–19.5)
Geographic region <0.001 <0.001
 Northeast 2393 15.2 (12.5–17.9) 6.5 (5.1–7.9) 4.7 (3.6–5.8)
 Midwest 3283 27.3 (22.3–32.3) 12.1 (10.2–14.0) 10.8 (8.5–13.1)
 South 4416 38.8 (33.8–43.8) 13.5 (11.8–15.3) 14.2 (12.7–15.8)
 West 2604 18.8 (15.8–21.7) 14.8 (12.4–17.1) 12.3 (10.7–13.8)
Year <0.001 <0.001
 2014 3066 20.7 (17.7–23.8) 14.5 (12.4–16.6) 16.1 (13.5–18.8)
 2015 2875 21.3 (18.5–24.0) 14.9 (12.5–17.2) 14.0 (11.6–16.3)
 2016 2429 21.1 (18.3–23.9) 11.4 (9.5–13.3) 11.3 (9.5–13.1)
 2017 2049 20.2 (17.1–23.4) 10.9 (8.8–13.1) 9.0 (7.1–10.8)
 2018 2274 16.7 (14.0–19.3) 9.0 (7.0–11.1) 5.7 (4.1–7.3)
Visit characteristics
Hospital type 0.10 0.10
 Pediatric ED 186 1.0 (0.1–1.9) 8.3 (4.0–12.7) 4.0 (0.0–9.6)
 General ED 12,507 99.0 (98.1–99.9) 12.3 (11.3–13.4) 11.5 (10.5–12.5)
Immediacy with which to be seen <0.001 0.9
 Unknown/Blank/No triage 2270 17.2 (13.1–21.2) 12.7 (10.1–15.3) 11.3 (8.2–14.3)
 Urgent/Emergent/Immediate 5017 40.3 (37.6–43.0) 8.3 (7.2–9.5) 11.4 (9.8–13.0)
 Semiurgent/Nonurgent 5406 42.6 (39.5–45.7) 15.9 (14.5–17.3) 11.6 (10.3–12.8)
Patient preexisting conditions
Asthma 0.04 0.07
  No 11,134 88.1 (87.1–89.1) 12.6 (11.4–13.7) 11.8 (10.7–12.9)
  Yes 1559 11.9 (10.9–12.9) 10.2 (8.3–12.1) 9.2 (6.9–11.5)
Depression 0.40 0.003
  No 11,730 97.0 (96.3–97.7) 12.4 (11.3–13.4) 11.8 (10.8–12.8)
  Yes 963 3.0 (2.3–3.7) 11.1 (8.3–13.9) 7.3 (4.8–9.8)
Obesity 0.09 0.20
  No 12,387 97.0 (96.3–97.7) 12.2 (11.2–13.2) 11.4 (10.4–12.4)
  Yes 306 3.0 (2.3–3.7) 16.7 (10.9–22.4) 14.7 (8.7–20.7)
Providers seen
ED attending physician <0.001 0.70
 No 1813 17.4 (14.3–20.4) 8.0 (6.4–9.7) 11.9 (8.8–15.0)
 Yes 10,880 82.6 (79.6–85.7) 13.2 (12.1–14.3) 11.4 (10.4–12.4)
Consulting physician <0.001 0.80
 No 11,829 93.8 (92.9–94.8) 11.8 (10.8–12.8) 11.5 (10.5–12.5)
 Yes 864 6.2 (5.2–7.1) 20.0 (16.3–23.7) 11.1 (7.3–14.9)
Imaging Ordered
CT scan (any) <0.001 <0.001
 No 11,367 88.7 (87.7–89.8) 10.0 (9.1–10.8) 10.5 (9.5–11.6)
 Yes 1326 11.3 (10.2–12.3) 30.7 (27.2–34.1) 18.7 (16.0–21.4)
X-ray <0.001 <0.001
 No 9108 70.0 (68.8–71.3) 10.8 (9.7–11.9) 9.7 (8.8–10.7)
 Yes 3585 30.0 (28.7–31.2) 15.9 (14.1–17.6) 15.5 (13.5–17.5)
Ultrasound <0.001 0.60
 No 11,915 93.8 (92.9–94.6) 11.5 (10.5–12.5) 11.4 (10.4–12.4)
 Yes 778 6.2 (5.4–7.1) 24.0 (19.2–28.7) 12.2 (9.5–14.9)
Nonopioid analgesics ordered 0.20 0.01
 No 8049 62.4 (60.9–63.9) 11.8 (10.5–13.1) 10.6 (9.4–11.7)
 Yes 4644 37.6 (36.1–39.1) 13.1 (11.5–14.6) 13.0 (11.3–14.6)
Pain score, mean (95% CI) 5.0 (4.9–5.1) 7.4 (7.2–7.6) <0.001 7.0 (6.8–7.3) <0.001

*Reflects row percentages.

P values correspond to weighted t tests and Rao-Scott χ2 tests, where appropriate.